# Metabolics Pharma, Inc. — Form D

Metabolics Pharma, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-19. The offering totals $6.3M, of which $5.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-09-19
- Form: D
- Accession: 0001878646-24-000026
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $6.3M
- Amount sold: $5.5M
- Remaining: $773K
- Investors: 7
- Date of first sale: 2024-09-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-524521

## Issuer

- Name: Metabolics Pharma, Inc.
- CIK: 0002037862
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 2005 MARKET STREET, PHILADELPHIA, PA, 19103
- Phone: 215-372-8031

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Jay A Brammer | Director | Philadelphia, PA |
| John A Dessouki | Director | Philadelphia, PA |
| Mark A Finn | Director | Philadelphia, PA |
| Mark A Kamp | Director | Philadelphia, PA |
| Richard Larson | Director | Signal Hill, CA |
| Barry A Miller | Director | Philadelphia, PA |
| John A Dessouki | Executive Officer | Philadelphia, PA |
| Richard Larson | Executive Officer | Signal Hill, CA |

## More

- [CIK 2037862 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2037862&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001878646-24-000026.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.